54.86
Biomarin Pharmaceutical Inc (BMRN) 最新ニュース
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock - Yahoo Finance
Take Care Before Diving Into The Deep End On BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - 富途牛牛
Pompe Disease Market Analysis Report 2025-2035: Enzyme Replacement Therapies and Approvals of Myozyme and Nexviazyme Drive Steady Growth - GlobeNewswire Inc.
How institutional ownership impacts BioMarin Pharmaceutical Inc. stockEarnings Risk Summary & Real-Time Volume Analysis Alerts - newser.com
BioMarin: Valuation, Growth, And The Pipeline May Outweigh TransCon Competition And Regulatory Risks - Seeking Alpha
Tealwood Asset Management Inc. Increases Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Raymond James Maintains a Buy Rating on BioMarin Pharmaceutical (BMRN), Sets a $85 PT - Yahoo
Real time alert setup for BioMarin Pharmaceutical Inc. performanceCPI Data & Fast Moving Trade Plans - newser.com
Can BioMarin Pharmaceutical Inc. stock reach $100 price targetEarnings Trend Report & Precise Trade Entry Recommendations - newser.com
How BioMarin Pharmaceutical Inc. stock performs in stagflationRate Cut & Daily Profit Maximizing Trade Tips - newser.com
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a Compelling 78% Upside Potential - DirectorsTalk Interviews
Is BioMarin Pharmaceutical Inc a good long term investmentRetail Investor Activity & Optimize Entry & Exit With Smart Signals - earlytimes.in
What analysts say about BioMarin Pharmaceutical Inc stockInsider Selling Patterns & Budget Friendly Trading Strategies - earlytimes.in
Is BioMarin Pharmaceutical Inc BM8 a good long term investmentPrice Volatility Patterns & Superior Wealth Growth - earlytimes.in
BioMarin Pharmaceutical Hits New 52-Week Low at $52.48 - Markets Mojo
Is BioMarin Pharmaceutical Inc. stock a safe buy before earningsPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com
Wealth Enhancement Advisory Services LLC Raises Stock Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Biomarin Pharmaceutical stock hits 52-week low at $52.93 By Investing.com - Investing.com Nigeria
Perpetual Ltd Acquires New Stake in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Biomarin Pharmaceutical stock hits 52-week low at $52.93 - Investing.com India
BioMarin Pharmaceutical (NASDAQ:BMRN) Reaches New 12-Month LowTime to Sell? - MarketBeat
BioMarin Pharmaceutical Inc. $BMRN Shares Acquired by Covea Finance - MarketBeat
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Short Interest Update - MarketBeat
Strs Ohio Buys Shares of 16,000 BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
BioMarin Pharmaceutical Inc.(NasdaqGS: BMRN) dropped from FTSE All-World Index - MarketScreener
Assenagon Asset Management S.A. Purchases 230,362 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Acadian Asset Management LLC Reduces Stake in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Aug Movers: Why is BioMarin Pharmaceutical Inc. stock going upOil Prices & Community Trade Idea Sharing - خودرو بانک
BioMarin Pharmaceutical Inc. $BMRN Shares Sold by Intech Investment Management LLC - MarketBeat
Performance Recap: Should I invest in BioMarin Pharmaceutical Inc before earningsJuly 2025 Decliners & Expert Verified Movement Alerts - خودرو بانک
Wesbanco Bank Inc. Purchases 19,000 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term - sharewise.com
Aug PreEarnings: What is the target price for BioMarin Pharmaceutical Inc stockBond Market & Fast Gain Stock Trading Tips - خودرو بانک
Aug Action: Is BioMarin Pharmaceutical Inc. stock forming a cup and handleWeekly Trend Summary & Stepwise Swing Trade Plans - khodrobank.com
12 Best Beginner Stocks to Buy According to Analysts - Insider Monkey
Ideas Watch: How does BioMarin Pharmaceutical Inc score in quality rankingsEarnings Performance Report & Real-Time Buy Signal Notifications - خودرو بانک
Levels Update: Can BioMarin Pharmaceutical Inc. scale operations efficientlyQuarterly Trade Summary & Consistent Growth Equity Picks - khodrobank.com
BioMarin Pharmaceutical Inc.’s (BMRN) Phenylketonuria Candidate Drug Impresses in Phase 3 Trials - Insider Monkey
November 21st Options Now Available For BioMarin Pharmaceutical (BMRN) - Nasdaq
Leerink Partners Reiterates a Buy Rating on BioMarin Pharmaceutical (BMRN), Sets a PT of $105 - MSN
BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Goldman Sachs Group Inc. - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $75.28 Million Stake in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
BMO Capital Reiterates a Buy on BioMarin Pharmaceutical (BMRN) - MSN
大文字化:
|
ボリューム (24 時間):